article_snippet.sent: Karen Langhart said doctors removed the NuvaRing immediately.
article_snippet.sent: NuvaRing is one of the most popular birth control products on the market.
article_snippet.sent: A flexible ring inserted vaginally, NuvaRing releases a combination of hormones.
article_snippet.sent: NuvaRing was approved by the FDA in 2001 and became available to women in the United States in 2002.  
article_snippet.sent: According to Merck, NuvaRing is sold in more than 50 countries, and 44 million prescriptions have been filled for women in the United States alone.
article_snippet.sent: NuvaRing dispenses what's called a third-generation progestin, or synthetic hormone.
article_snippet.sent: When The NuvaRing dispenses what's called a third-generation progestin, or synthetic hormone first came on the market, the device was touted as a breakthrough -- inserted vaginally to release a "continuous low dose of hormones.
article_snippet.sent: The Langharts had no idea the NuvaRing birth control whom daughter had been using for four years had already been linked to other women's deaths, according to unconfirmed claims of problems reported to the FDA.
article_snippet.sent: NuvaRing users are on the higher end of that risk.
article_snippet.sent: NuvaRing's label was updated in 2013 by the FDA with information about both studies.
article_snippet.sent: According to claims filed in federal and state courts, the lawsuits allege Organon, the original manufacturer of NuvaRing, "failed to adequately warn consumers about a heightened risk of blood clots associated with the use of NuvaRing, even though the manufacturer was aware that the NuvaRing posed greater risks than other hormonal contraceptives.
article_snippet.sent: Instead, to honor Erika's memory, them decided to create a nonprofit to inform women of the dangers them believe are related to the NuvaRing and the comparative risks of all forms of hormonal contraceptives.
highlights_snippet.sent: The NuvaRing is one of the most popular birth control products on the market .
  
highlights_snippet.sent: Lawsuit cites "a heightened risk of blood clots associated with the use of NuvaRing"
  Maker:
highlights_snippet.sent: "There is substantial evidence to support the safety and efficacy of NuvaRing" 